My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 160

    2.

    Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.

    Marx N, Duez H, Fruchart JC, Staels B.

    Circ Res. 2004 May 14;94(9):1168-78. Review.PMID: 15142970 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Peroxisome proliferator-activated receptors and the control of inflammation.

    Cabrero A, Laguna JC, Vázquez M.

    Curr Drug Targets Inflamm Allergy. 2002 Sep;1(3):243-8. Review.PMID: 14561188 [PubMed - indexed for MEDLINE]Related articles

    4.

    Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.

    Sertznig P, Seifert M, Tilgen W, Reichrath J.

    Am J Clin Dermatol. 2008;9(1):15-31. Review.PMID: 18092840 [PubMed - indexed for MEDLINE]Related articles

    5.

    Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.

    Chinetti G, Fruchart JC, Staels B.

    Inflamm Res. 2000 Oct;49(10):497-505. Review.PMID: 11089900 [PubMed - indexed for MEDLINE]Related articles

    6.

    Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.

    Bility MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, Peters JM.

    Toxicol Sci. 2004 Nov;82(1):170-82. Epub 2004 Aug 13.PMID: 15310864 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.

    Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W.

    Pharmacol Rev. 2006 Dec;58(4):726-41. Review.PMID: 17132851 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?

    Melnick RL.

    Environ Health Perspect. 2001 May;109(5):437-42. Review.PMID: 11401753 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells.

    Han S, Sidell N, Fisher PB, Roman J.

    Clin Cancer Res. 2004 Mar 15;10(6):1911-9.PMID: 15041706 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Peroxisome proliferator-activated receptors and inflammation.

    Moraes LA, Piqueras L, Bishop-Bailey D.

    Pharmacol Ther. 2006 Jun;110(3):371-85. Epub 2005 Sep 15. Review.PMID: 16168490 [PubMed - indexed for MEDLINE]Related articles

    11.

    Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.

    Jia Y, Qi C, Kashireddi P, Surapureddi S, Zhu YJ, Rao MS, Le Roith D, Chambon P, Gonzalez FJ, Reddy JK.

    J Biol Chem. 2004 Jun 4;279(23):24427-34. Epub 2004 Mar 29.PMID: 15150259 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.

    Touyz RM, Schiffrin EL.

    Vascul Pharmacol. 2006 Jul;45(1):19-28. Epub 2006 Jun 16. Review.PMID: 16782410 [PubMed - indexed for MEDLINE]Related articles

    13.

    Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).

    Chevalier S, Roberts RA.

    Oncol Rep. 1998 Nov-Dec;5(6):1319-27. Review.PMID: 9769363 [PubMed - indexed for MEDLINE]Related articles

    14.

    Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.

    Guan Y, Breyer MD.

    Kidney Int. 2001 Jul;60(1):14-30. Review.PMID: 11422732 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    PPARalpha agonist-induced rodent tumors: modes of action and human relevance.

    Klaunig JE, Babich MA, Baetcke KP, Cook JC, Corton JC, David RM, DeLuca JG, Lai DY, McKee RH, Peters JM, Roberts RA, Fenner-Crisp PA.

    Crit Rev Toxicol. 2003;33(6):655-780. Review.PMID: 14727734 [PubMed - indexed for MEDLINE]Related articles

    16.

    The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.

    Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE.

    Mol Endocrinol. 2003 Dec;17(12):2477-93. Epub 2003 Oct 2.PMID: 14525954 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development]

    Alemán G, Torres N, Tovar AR.

    Rev Invest Clin. 2004 May-Jun;56(3):351-67. Review. Spanish. PMID: 15612519 [PubMed - indexed for MEDLINE]Related articles

    19.

    Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator.

    Tien ES, Davis JW, Vanden Heuvel JP.

    J Biol Chem. 2004 Jun 4;279(23):24053-63. Epub 2004 Mar 29.PMID: 15051727 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Mono(2-ethylhexyl)phthalate and mono-n-butyl phthalate activation of peroxisome proliferator activated-receptors alpha and gamma in breast.

    Venkata NG, Robinson JA, Cabot PJ, Davis B, Monteith GR, Roberts-Thomson SJ.

    Toxicol Lett. 2006 Jun 1;163(3):224-34. Epub 2005 Dec 1.PMID: 16326050 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk